Found: 34
Select item for more details and to access through your institution.
Letter: to switch or not to switch, that is the question.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 920, doi. 10.1111/apt.17112
- By:
- Publication type:
- Article
Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 783, doi. 10.1111/apt.17089
- By:
- Publication type:
- Article
Synchronous occurrence of different polyp types during colonoscopy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 777, doi. 10.1111/apt.17075
- By:
- Publication type:
- Article
Letter: long‐term abdominal drains in cirrhosis—a solution or a new problem? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 926, doi. 10.1111/apt.17168
- By:
- Publication type:
- Article
Editorial: rectal hyposensitivity in patients with hypermobile Ehlers‐Danlos syndrome and constipation—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 907, doi. 10.1111/apt.17163
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: percutaneous placement of a permanent tunnelled catheter for patients with non‐malignant ascites ‐ is it safe? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 911, doi. 10.1111/apt.17157
- By:
- Publication type:
- Article
Letter: long‐term abdominal drains in cirrhosis – a solution or a new problem?
- Published in:
- 2022
- Publication type:
- Letter to the Editor
Editorial: paternal use of IBD therapies and risk of infant infection.
- Published in:
- 2022
- Publication type:
- Editorial
Letter: to switch or not to switch, that is the question—author's reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 922, doi. 10.1111/apt.17147
- By:
- Publication type:
- Article
Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients—author's reply.
- Published in:
- 2022
- Publication type:
- Case Study
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease—authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta—new life for an old timer? Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Editorial: serum triiodothyronine‐to‐thyroxine (T3/T4) ratio as biomarker of response in IBD ‐ an open issue.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with IBD.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: further support for exclusive enteral nutrition in paediatric Crohn's disease.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: rectal hyposensitivity in patients with hypermobile Ehlers‐Danlos syndrome and constipation.
- Published in:
- 2022
- Publication type:
- Editorial
Impact of Rome IV irritable bowel syndrome on work and activities of daily living.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 844, doi. 10.1111/apt.17132
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 759, doi. 10.1111/apt.16427
- Publication type:
- Article
Editorial: reducing false alarms with oesophagogastric junction outflow obstruction.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg‐positive chronic hepatitis B Patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 878, doi. 10.1111/apt.17124
- By:
- Publication type:
- Article
Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 857, doi. 10.1111/apt.17123
- By:
- Publication type:
- Article
Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 869, doi. 10.1111/apt.17120
- By:
- Publication type:
- Article
Risk of dementia in patients with inflammatory bowel disease: a Danish population‐based study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 831, doi. 10.1111/apt.17119
- By:
- Publication type:
- Article
Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta—new life for an old timer?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Paternal use of medications for inflammatory bowel disease and the risk of hospital‐diagnosed infections in the offspring: a nationwide cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 823, doi. 10.1111/apt.17113
- By:
- Publication type:
- Article
The association between inflammatory bowel disease and mental ill health: a retrospective cohort study using data from UK primary care.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 814, doi. 10.1111/apt.17110
- By:
- Publication type:
- Article
Review article: novel biomarkers in hepatitis B infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 760, doi. 10.1111/apt.17105
- By:
- Publication type:
- Article
Rectal hyposensitivity: a common pathophysiological finding in patients with constipation and associated hypermobile Ehlers–Danlos syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 802, doi. 10.1111/apt.17104
- By:
- Publication type:
- Article
Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non‐malignant ascites—Is it safe?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real‐world patient mix.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 794, doi. 10.1111/apt.17092
- By:
- Publication type:
- Article